trending Market Intelligence /marketintelligence/en/news-insights/trending/jtl01cyg1xqyyiqzhaxdaw2 content esgSubNav
In This List

Immune Pharmaceuticals director resigns

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Immune Pharmaceuticals director resigns

Immune Pharmaceuticals Inc. said Cameron Durrant resigned as a director.

Englewood Cliffs, N.J.-based Immune Pharmaceuticals develops treatments for immunologic and inflammatory diseases.